NASDAQ: EWCZEuropean Wax Center Inc Stock
$6.49-0.29 (-4.28%)
Updated Oct 14, 2024
EWCZ Price
$6.49
Fair Value Price
-$2.52
Market Cap
$389.27M
52 Week Low
$4.80
52 Week High
$16.76
P/E
24.96x
P/B
4.59x
P/S
2.17x
PEG
2.04x
Dividend Yield
N/A
Revenue
$223.79M
Earnings
$12.55M
Gross Margin
72.8%
Operating Margin
20.23%
Profit Margin
5.6%
Debt to Equity
7.2
Operating Cash Flow
$60M
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
EWCZ Overview
European Wax Center, Inc. operates and franchises out-of-home body waxing services in the U.S. It offers hygienic waxing services administered by its estheticians it trains. Besides body and facial waxing services, European Wax Center provides pre- and post-service products, including ingrown hair serums, exfoliating gels, brow shapers, and skin treatments. European Wax Center was founded in 2004 and is headquartered in Plano, TX.
Zen Score
–
Industry Average (37)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EWCZ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EWCZ ($6.49) is overvalued by 357.22% relative to our estimate of its Fair Value price of -$2.52 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
EWCZ ($6.49) is not significantly undervalued (357.22%) relative to our estimate of its Fair Value price of -$2.52 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
EWCZ ($6.49) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EWCZ due diligence checks available for Premium users.
Be the first to know about important EWCZ news, forecast changes, insider trades & much more!
EWCZ News
Valuation
EWCZ fair value
Fair Value of EWCZ stock based on Discounted Cash Flow (DCF)
Price
$6.49
Fair Value
-$2.52
Undervalued by
357.22%
EWCZ ($6.49) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EWCZ ($6.49) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EWCZ ($6.49) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
EWCZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
24.96x
Industry
32.24x
Market
27.44x
EWCZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EWCZ is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
EWCZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.59x
Industry
7.76x
EWCZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EWCZ price to earnings growth (PEG)
For valuing profitable companies with growth potential
EWCZ is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
EWCZ's financial health
Profit margin
Revenue
$59.9M
Net Income
$4.3M
Profit Margin
7.2%
EWCZ's Earnings (EBIT) of $45.27M... subscribe to Premium to read more.
Interest Coverage Financials
EWCZ's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$727.9M
Liabilities
$610.9M
Debt to equity
7.2
EWCZ's short-term assets ($100.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EWCZ's long-term liabilities ($582.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EWCZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$14.4M
Investing
-$185.0k
Financing
-$18.9M
EWCZ's operating cash flow ($59.51M)... subscribe to Premium to read more.
Debt Coverage Financials
EWCZ vs Household & Personal Product Stocks
European Wax Center Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.